Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2008 1
2009 1
2010 1
2011 1
2012 1
2013 1
2015 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Modes of resistance to anti-angiogenic therapy.
Bergers G, Hanahan D. Bergers G, et al. Nat Rev Cancer. 2008 Aug;8(8):592-603. doi: 10.1038/nrc2442. Nat Rev Cancer. 2008. PMID: 18650835 Free PMC article. Review.
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, Bergers G, Aghi MK. Jahangiri A, et al. Clin Cancer Res. 2013 Apr 1;19(7):1773-83. doi: 10.1158/1078-0432.CCR-12-1281. Epub 2013 Jan 10. Clin Cancer Res. 2013. PMID: 23307858 Free PMC article.